LETROZOLE NEAPOLIS 2.5 MG BT 30

Adjuvant treatment of early-stage breast cancer (in the presence of positive estrogen and progesterone receptors or unknown status) in postmenopausal women.

Adjuvant treatment of early-stage breast cancer (in the presence of positive estrogen and progesterone receptors or unknown status) in postmenopausal women who have received adjuvant treatment with tamoxifen for 5 years (extended adjuvant therapy).

Treatment of advanced-stage breast cancer in postmenopausal women (natural or artificial menopause) whose tumor shows positive receptors for estrogen or progesterone or if their status is unknown.